Navigation Links
Amgen To Acquire Onyx Pharmaceuticals For $125 Per Share In Cash
Date:8/25/2013

THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif., Aug. 25, 2013 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) today announced that their Boards of Directors have unanimously approved a transaction under which Amgen will acquire all of the outstanding shares of Onyx for $125 per share in cash.  The purchase price is $10.4 billion, or $9.7 billion net of estimated Onyx cash. 

Onyx Pharmaceuticals, Inc. is a global biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer.  Onyx has an important and growing multiple myeloma franchise, with Kyprolis® (carfilzomib) for Injection already approved in the United States (U.S.). In addition, Onyx has three partnered oncology assets: Nexavar® (sorafenib) tablets (an Onyx and Bayer HealthCare Pharmaceuticals, Inc. compound), Stivarga® (regorafenib) tablets (a Bayer compound), and palbociclib (a Pfizer, Inc. compound).  Onyx also has multiple oncology compounds in various stages of clinical development.

Amgen intends to effect the transaction through a tender offer and expects to close at the beginning of the fourth quarter, subject to the satisfaction of customary closing conditions, including the receipt of regulatory clearance."We believe that Amgen is ideally suited to realize the full potential of Onyx's portfolio and pipeline for the benefit of physicians and patients," said Robert A. Bradway, chairman and chief executive officer at Amgen.  "Our acquisition of Onyx follows a thorough due diligence process and is fully consiste
'/>"/>

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine technology :

1. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
2. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
3. Amgen to Present at the Baird Growth Stock Conference
4. Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars
5. Amgens BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
6. Amgen Announces Top-Line Results Of Phase 3 Sensipar®/Mimpara® EVOLVE™ Trial
7. Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals
8. Amgen Completes Acquisition of KAI Pharmaceuticals
9. Amgens Second Quarter 2012 Revenues Increased 13 Percent To $4.5 Billion And Adjusted Earnings Per Share (EPS) Increased 34 Percent To $1.83
10. Amgen Announces Termination Of Ganitumab Phase 3 Study For Futility In Metastatic Pancreatic Cancer
11. Amgen To Present At The Baird Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... 20, 2015 Research and ... the "Global Pressure Relief Devices Market 2015-2019" ... Relief Devices market to grow at a CAGR of ... Pressure Relief Devices Market 2015-2019, has been prepared based ... experts. The report covers the Americas, and the APAC ...
(Date:7/27/2015)... 27, 2015  Attorney Advertising-- Bronstein, Gewirtz & Grossman, ... purchasers of the securities of AMAG Pharmaceuticals Inc. ... investors are advised to contact Peretz Bronstein ... Kimelman at info@bgandg.com or 212-697-6484. ... certain of its officers and/or directors have violated ...
(Date:7/27/2015)... , July 20, 2015 Research and Markets ... "Medical Device Regulation in Asia/Pacific Markets Seminar" ... the European Medical Device market is well established, the ... China , together with other countries ... the process of implementing, their own medical device regulations. ...
Breaking Medicine Technology:Global Pressure Relief Devices Market 2015-2019 with ArjoHuntleigh, Hill-Rom, Paramount Bed Holdings & Stryker Dominating 2SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals Inc. 2Medical Device Regulation in Asia/Pacific Markets Seminar: London, UK - 21st, 22nd of September 2015 2
... Myocor, Inc. announced that,the U.S. Food and ... Valvular and Ventricular Improvement Via iCoapsys Delivery ... evaluate the,safety and feasibility of the percutaneously ... valve insufficiency caused by left,ventricular dysfunction and ...
... Senesco,Technologies, Inc. ("Senesco" or the "Company") (Amex: ... lab studies at Mayo Clinic focused,on multiple myeloma. ... Factor 5A gene technology to up-regulate apoptosis of ... for,encapsulation of Factor 5A to enhance the time ...
Cached Medicine Technology:Myocor Receives Approval for Percutaneous Trial 2Senesco Technologies Initiates Preclinical Studies for Cancer Target 2
(Date:7/27/2015)... NJ (PRWEB) , ... July 27, 2015 , ... ... entitled "Applying Data To Reduce Hospital Readmissions." , The Centers for Medicare and ... facility-level data used as part of their penalty calculation. Known as the QualityNet ...
(Date:7/27/2015)... ... July 27, 2015 , ... At Champagne Smiles, they know that ... loss can incur a lot of stress, pain, discomfort and embarrassment, which is why ... All-On-4™ treatment reaps the benefits of implants with the cost savings of dentures for ...
(Date:7/27/2015)... ... , ... According to an article published by the Times Free Press ... stemming from intravenous drug use. Intravenous drug use causes more overdoses and is responsible ... including Hepatitis B and C and HIV. Drug treatment facilities in Tennessee have witnessed ...
(Date:7/27/2015)... (PRWEB) , ... July 27, 2015 , ... ... of fullerenes in medical and diagnostics applications is rapidly increasing and is driven ... and cancer treatment, they are increasingly being evaluated for use in bio implants. ...
(Date:7/27/2015)... ... ... Sher Fertility Institute, a national network of fertility clinics known ... their clinical team in Las Vegas. , Dr. Mark Severino joins ... Endocrinology teams in the region. , Combined Drs. Sher and Severino have more than ...
Breaking Medicine News(10 mins):Health News:BESLER Consulting Publishes E-book Focused on Reducing Hospital Readmissions 2Health News:NJ Top Dentists Presents, Dr. Richard Champagne of Champagne Smiles! 2Health News:NJ Top Dentists Presents, Dr. Richard Champagne of Champagne Smiles! 3Health News:NJ Top Dentists Presents, Dr. Richard Champagne of Champagne Smiles! 4Health News:Tennessee Sees an Increase in Hepatitis C Infections from Intravenous Heroin Use 2Health News:Tennessee Sees an Increase in Hepatitis C Infections from Intravenous Heroin Use 3Health News:Fullerene Market to Grow at 13% CAGR to 2019 Says a New Research Report at Sandlerresearch.org 2Health News:Fullerene Market to Grow at 13% CAGR to 2019 Says a New Research Report at Sandlerresearch.org 3Health News:Dr. Mark Severino Joins Dr. Geoffrey Sher at Sher Fertility Las Vegas- Sher Fertility is National Network of Fertility Clinics Known for Exceptional Patient Care 2Health News:Dr. Mark Severino Joins Dr. Geoffrey Sher at Sher Fertility Las Vegas- Sher Fertility is National Network of Fertility Clinics Known for Exceptional Patient Care 3
... the risk of developing breast cancer, says a new ... between handedness// and incidence of breast cancer in over ... 1941, reports science portal EurekAlert. ,They recorded ... economic status, smoking habits, family history of breast cancer, ...
... Wake Forest University Baptist Medical Center have begun a ... synthetic steroids to prevent premature babies//., ,Premature infants ... fully developed. Currently the best treatments are to give ... for as long as possible. ,Sheep will ...
... designed a plastic device which helps in prevention of ... patients//. The scarring in these cancer patients hinders the ... to reduce the risk of scarring in women undergoing ... ,Joan Thomas, is Macmillan Nurse specialist who has ...
... chemicals has been known to be associated with health ... But it is known not until recently that rheumatoid ... to mineraloil., ,The exact causative factor rheumatiod factor ... and environmental fcators have been help responsible to a ...
... might help lower the negative impact on a person's blood ... that job strain had a significant impact, both clinically and ... low marital cohesion, or a lack of support from a ... of blood pressure over one year. High marital cohesion in ...
... to lose the excess weight that one has to carry like ... best way is that adopted earlier that is the basic principle ... Obesity is a big problem these days., ,Calorie counting ... towards weight control., ,With so many dietary plans jostling for ...
Cached Medicine News:
Full plate covers seal all 24 MicroAmp tubes...
Omniseal TD mat. Reusable rubber mat for sealing PCR plates. 5 pk....
Inquire...
... A soft, heat-resistant, aluminum foil film ... AlumaSeal II minimizes evaportaion and vapor ... need for heat-sealing devices or mats. ... sovents and reagents. Compared to other ...
Medicine Products: